Skip to content
Open access · CC-BY via OpenAlex

Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes

Sangeeta Rao Kashyap, Deepak L. Bhatt, Kathy Wolski, Richard M. Watanabe, Muhammad A Abdul‐Ghani, Beth Abood, Claire E. Pothier, Stacy A. Brethauer, Steven E. Nissen, Manjula K. Gupta, John P. Kirwan, Philip R. Schauer

Diabetes Care · 2013 · ▲ 292 citations

Abstract

OBJECTIVE: To evaluate the effects of two bariatric procedures versus intensive medical therapy (IMT) on β-cell function and body composition. RESEARCH DESIGN AND METHODS: This was a prospective, randomized, controlled trial of 60 subjects with uncontrolled type 2 diabetes (HbA1c 9.7 ± 1%) and moderate obesity (BMI 36 ± 2 kg/m(2)) randomized to IMT alone, IMT plus Roux-en-Y gastric bypass, or IMT plus sleeve gastrectomy. Assessment of β-cell function (mixed-meal tolerance testing) and body composition was performed at baseline and 12 and 24 months. RESULTS: Glycemic control improved in all three groups at 24 months (N = 54), with a mean HbA1c of 6.7 ± 1.2% for gastric bypass, 7.1 ± 0.8% for sleeve gastrectomy, and 8.4 ± 2.3% for IMT (P < 0.05 for each surgical group versus IMT). Reduction in body fat was similar for both surgery groups, with greater absolute reduction in truncal fat in gastric bypass versus sleeve gastrectomy (-16 vs. -10%; P = 0.04). Insulin sensitivity increased significantly from baseline in gastric bypass (2.7-fold; P = 0.004) and did not change in sleeve gastrectomy or IMT. β-Cell function (oral disposition index) increased 5.8-fold in gastric bypass from baseline, was markedly greater than IMT (P = 0.001), and was not different between sleeve gastrectomy versus IMT (P = 0.30). At 24 months, β-cell function inversely correlated with truncal fat and prandial free fatty acid levels. CONCLUSIONS: Bariatric surgery provides durable glycemic control compared with intensive medical therapy at 2 years. Despite similar weight loss as sleeve gastrectomy, gastric bypass uniquely restores pancreatic β-cell function and reduces truncal fat, thus reversing the core defects in diabetes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2337/dc12-1596
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Kashyap, S.R., Bhatt, D.L., Wolski, K., Watanabe, R.M., Abdul‐Ghani, M.A., Abood, B., Pothier, C.E., Brethauer, S.A., Nissen, S.E., Gupta, M.K., Kirwan, J.P., &amp; Schauer, P.R. (2013). Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes. <em>Diabetes Care</em>. https://doi.org/10.2337/dc12-1596
Vancouver
Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul‐Ghani MA, Abood B, et al. Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes. Diabetes Care. 2013. doi:10.2337/dc12-1596.
BibTeX
@article{sangeeta2013Metabo, title = {Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes}, author = {Sangeeta Rao Kashyap and Deepak L. Bhatt and Kathy Wolski and Richard M. Watanabe and Muhammad A Abdul‐Ghani and Beth Abood and Claire E. Pothier and Stacy A. Brethauer and Steven E. Nissen and Manjula K. Gupta and John P. Kirwan and Philip R. Schauer}, journal = {Diabetes Care}, year = {2013}, doi = {10.2337/dc12-1596}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings